<DOC>
	<DOCNO>NCT00167960</DOCNO>
	<brief_summary>To determine impact restriction third forth generation cephalosporin reduction intestinal colonization infection vancomycin-resistant enterococci ( VRE ) surgical intensive care unit ( SICU )</brief_summary>
	<brief_title>Study Evaluating Vancomycin-Resistant Enterococci Hematology Unit</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<criteria>All patient admit transferred SICU . Eligible patient patient either sex , 18 year age older admit transfer SICU . Provide write informed consent Patients hypersensitivity penicillin , cephalosporins betalactamase inhibitor . Females pregnant breast feed Any underlying condition noninfectious disease ultimately fatal within 48 hour . Those already participate clinical study relate antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Bacterial Infections</keyword>
</DOC>